Haemato-oncology, myeloma, other plasma cell dyscrasias, stem cell transplantation and cancer clinical trials.
Current NHS post
Consultant Haematologist, Oxford University Hospitals NHS Trust.
- Member, National Cancer Research Institute.
- Myeloma Studies Group.
- MCTN Meyeloma UK.
- Exec, UK Myeloma Forum.
- Member, American Society for Haematology.
- Member, British Society of Haematology.
- Member, British Society of Bone and Marrow Transplantation.
Profile of Dr Karthik Ramasamy
Dr Karthik Ramasamy has established a strong myeloma and other plasma cell dyscrasias clinical practice in Oxford. He is the Lead Clinician for myeloma and other plasma dyscrasias in Thames Valley Strategic Clinical Network. He is a Chief Investigator of national myeloma studies and Principal Investigator of a number of myeloma trials.
Dr Ramasamy has recently been appointed as Divisional Lead of Cancer Research across Thames Valley and South Midlands Research Network.